Rankings
▼
Calendar
MDXG Q4 2016 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena
MDXG
MiMedx Group, Inc.
$666M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$70M
Gross Profit
$61M
87.0% margin
Operating Income
$9M
12.5% margin
Net Income
$5M
7.8% margin
EPS (Diluted)
$0.05
QoQ Revenue Growth
+8.5%
Cash Flow
Operating Cash Flow
$17M
Free Cash Flow
$15M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$193M
Total Liabilities
$60M
Stockholders' Equity
$133M
Cash & Equivalents
$34M
← FY 2016
All Quarters
Q1 2017 →